(Q35071446)

6 August 2017

1 reference

title

Rates of transmission of antiretroviral drug resistant strains of HIV-1. (English)

1 reference

6 August 2017

0 references

anti-retroviral agent

0 references

9

Anthony D Kelleher

1 reference

6 August 2017

Palanee Ammaranond

1

1 reference

6 August 2017

Philip Cunningham

2

1 reference

6 August 2017

Robert Oelrichs

3

1 reference

6 August 2017

Kazuo Suzuki

4

1 reference

6 August 2017

Claire Harris

5

1 reference

6 August 2017

Leakhena Leas

6

1 reference

6 August 2017

Andrew Grulich

7

1 reference

6 August 2017

David A Cooper

8

1 reference

6 August 2017

publication date

1 February 2003

1 reference

Journal of Clinical Virology

6 August 2017

published in

1 reference

6 August 2017

volume

26

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

153-161

1 reference

Risk and management of blood-borne infections in health care workers

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

Predicting the unpredictable: transmission of drug-resistant HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

HIV-1 drug resistance in newly infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

High Frequency of Non-B Subtypes in Newly Diagnosed HIV-1 Infections in Switzerland

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

The role of antiretrovirals and drug resistance in vertical transmission of HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

Emergence and genetic evolution of HIV-1 variants with mutations conferring resistance to multiple reverse transcriptase and protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

HIV-1 diversity in France, 1996-1998. The AC 11 laboratory network

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

Analysis of HIV type 1 protease and reverse transcriptase sequences from Venezuela for drug resistance-associated mutations and subtype classification: a UNAIDS study.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide study

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

1 reference

7 January 2021

Frequency of genotypic and phenotypic drug-resistant HIV-1 among therapy-naive patients of the German Seroconverter Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

Changes in the rate of genotypic resistance to antiretroviral drugs in Spain

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

Increased ability for selection of zidovudine resistance in a distinct class of wild-type HIV-1 from drug-naive persons

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

Carrier rate of zidovudine-resistant HIV-1: the impact of failing therapy on transmission of resistant strains.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

Transmission of human immunodeficiency virus type 1 resistant to nevirapine and zidovudine. Sydney Primary HIV Infection Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine-lamivudine-ritonavir: genotypic analysis of human immunodeficiency virus type 1 isolates from AIDS clinical trials group protocol 315.ACTG Protocol 315 Team

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

Reduced antiretroviral drug susceptibility among patients with primary HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

Highly drug-resistant HIV-1 clinical isolates are cross-resistant to many antiretroviral compounds in current clinical development

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

Altered viral fitness of HIV-1 following failure of protease inhibitor-based therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

Detection of drug resistance associated mutations in HIV primary infection within the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. Investigators of the Quebec Primary Infection Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

Prevalence of drug resistant mutants and virological response to combination therapy in patients with primary HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

Prevalence of HIV-1 drug resistance in antiretroviral-naive patients: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

Prevalence of genotypic and phenotypic resistance to anti-retroviral drugs in a cohort of therapy-naïve HIV-1 infected US military personnel

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

Prevalence of mutations associated with reduced antiretroviral drug susceptibility among human immunodeficiency virus type 1 seroconverters in the United States, 1993-1998.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

Transmission of antiretroviral-drug-resistant HIV-1 variants

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900114-2

7 January 2021

10.1016/S1386-6532(02)00114-2

Identifiers

DOI

1 reference

6 August 2017

1 reference